Photo: C. Seggewies

About 250 international guests followed MIRACUM's invitation to participate in the kick-off symposium.

Rurik Schnackig

Jakob-Herz-Prize awarded for the fifth time.


How likely do patients develop again cancer after a tumor has been surgically removed? This is the central question of the new research project „MelEVIR – Melanoma, Extracellular Vesicles, and Immune Response“.

Photo: S. Krikava the Faculty of Medicine at Friedrich-Alexander-Universität Erlangen-Nürnberg! Discover the excellent research conditions and the high quality of life in the region!

Faculty of Medicine

Lung cancer is the third most common type of cancer in Germany and the disease affects both men and women. However, immunotherapies are successful in only 20 percent of cases. Researchers of the Divisions of Molecular Pneumology and Thoracic Surgery have now discovered a special mechanism that regulates tumor growth in lung cancer.

Around 700,000 people die every year as a result of antibiotic resistance. Scientists have now discovered that there is a point in the production process of the proteins at which it can be regulated by bacteria. This could be used as a starting point for the development of new antibiotics and help overcome resistance to antibiotics.

Around 200,000 people in Germany suffer from multiple sclerosis. The causes are far from being fully understood. What is known is that the immune system erroneously attacks the protective sheaths around nerve fibres. Scientists have now discovered how the formation of these protective sheaths is regulated by protein molecules.

A groundbreaking project titled 'MoveIT' has been launched to analyze the gait and falls of people with Parkinson's. Using telemedicine based on sensors placed in patients' shoes and attached to their upper body, researchers aim to analyze specific characteristics in the patient's gait and when they fall.